
CooperVision expands multifocal range
CooperVision has launched the Clariti 1 Day multifocal contact lens in Australia and New Zealand. This daily disposable silicone hydrogel lens for presbyopic

CooperVision has launched the Clariti 1 Day multifocal contact lens in Australia and New Zealand. This daily disposable silicone hydrogel lens for presbyopic

Kirsty Pienaar has joined OPSM as regional manager north, overseeing 18 stores across Northland, Auckland, and Gisborne. A registered dispensing optician, she aims to drive performance, consistency, and customer experience

The Association of Dispensing Opticians of New Zealand (ADONZ) has withdrawn its support for the Australasian College of Optical Dispensing’s (ACOD) Certificate IV in Optical Dispensing, saying it wan…

Johnson and Johnson Vision’s (J&Js) breakthrough soft contact lens for myopia control, Acuvue Abiliti 1-Day, newly released data reveals over 55% of treated eyes showed no clinically meaningful myopia

Sun Pharma's Cequa (ciclosporin ophthalmic solution, 0.09%) for moderate to severe dry eye is now

New Zealand’s first dedicated uveitis conference, Uveitis Aotearoa 2026, will be held 31 July

NZ Optics' latest audience survey highlights the enduring value of trusted industry media, the continued strength of print, and opportunities to evolve digital communication. Respondents

A national pathway will enable community optometrists to provide routine four-week post-operative cataract follow-up care for public hospital patients across New Zealand, aiming to improve access and

EssilorLuxottica presented new research at ARVO 2026, including seven-year follow-up data, reinforcing the

Aspen Pharmacare is expanding its Medsafe registered Eikance atropine eye drop range in NZ to include 0.05% and 0.025% concentrations, offering tailored myopia control for children aged 4-14 years.

New research links glucosamine, a joint pain supplement, to a 25% higher likelihood of progression from mild cognitive impairment (MCI) to

Clinician-scientists identified bacterial pathogens linked to poorest outcomes in postprocedural acute endophthalmitis, potentially supporting faster, personalised treatment and improving patient